Geneos Wealth Management Inc. Adamis Pharmaceuticals Corp Transaction History

Geneos Wealth Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Sep 07, 2021	SELL	$0.51 - $1.26 $856 - $2,116	-1,680 Closed	0 $0
Q3 2018 Sep 07, 2021	BUY	$2.25 - $4.8 $1,125 - $2,400	500 Added 42.37%	1,680 $5,000
Q2 2018 Sep 07, 2021	SELL	$3.2 - $4.7 $1,600 - $2,350	-500 Reduced 29.76%	1,180 $3,000
Q2 2017 Sep 07, 2021	BUY	N/A	1,180 Added 236.0%	1,680 $8,000
Q3 2016 Sep 07, 2021	BUY	N/A	500	500 $1,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.